{
    "eid": "2-s2.0-85082179456",
    "title": "Comparing CAR T-cell toxicity grading systems: Application of the ASTCT grading system and implications for management",
    "cover-date": "2020-02-25",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Martina Pennisi",
        "Tania Jain",
        "Bianca D. Santomasso",
        "Elena Mead",
        "Kitsada Wudhikarn",
        "Mari Lynne Silverberg",
        "Yakup Batlevi",
        "Roni Shouval",
        "Sean M. Devlin",
        "Connie Batlevi",
        "Renier J. Brentjens",
        "Parastoo B. Dahi",
        "Claudia Diamonte",
        "Sergio Giralt",
        "Elizabeth F. Halton",
        "Molly Maloy",
        "Maria Lia Palomba",
        "Miriam Sanchez-Escamilla",
        "Craig S. Sauter",
        "Michael Scordo",
        "Gunjan Shah",
        "Jae H. Park",
        "Miguel Angel Perales"
    ],
    "citedby-count": 90,
    "ref-count": 20,
    "ref-list": [
        "Axicabtagene ciloleucel car t-cell therapy in refractory large b-cell lymphoma",
        "Chimeric antigen receptor T cells in refractory B-cell lymphomas",
        "Tisagenlecleucel in children and young adults with b-cell lymphoblastic leukemia",
        "Clinical utilization of chimeric antigen receptor t cells (car-t) in b-cell acute lymphoblastic leukemia (all): An expert opinion from the european society for blood and marrow transplantation (ebmt) and the American society for blood and marrow transplantation (asbmt)",
        "Use of chimeric antigen receptor t cell therapy in clinical practice for relapsed/refractory aggressive b cell non-hodgkin lymphoma: An expert panel opinion from the American society for transplantation and cellular therapy",
        "Current concepts in the diagnosis and management of cytokine release syndrome [published correction appears in Blood 126(8):1048]",
        "Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel [published correction appears in J Hematol Oncol. 2018; 11:81]",
        "Long-term follow-up of cd19 car therapy in acute lymphoblastic leukemia",
        "Chimeric antigen receptor T-cell therapy - Assessment and management of toxicities",
        "ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells",
        "Management of immunotherapy-related toxicities, version 1.2019",
        "Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): A single-arm, multicentre, phase 1-2 trial",
        "Tisagenlecleucel in adult relapsed or refractory diffuse large b-cell lymphoma",
        "Clinical and biological correlates of neurotoxicity associated with car t-cell therapy in patients with b-cell acute lymphoblastic leukemia",
        "Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and management",
        "Preliminary results of earlier steroid use with axicabtagene ciloleucel (axi-cel) in patients with relapsed/refractory large B-cell lymphoma (R/R LBCL) [abstract]"
    ],
    "affiliation": [
        {
            "affiliation-city": "New York",
            "@id": "60009343",
            "affilname": "Memorial Sloan-Kettering Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Milan",
            "@id": "60030318",
            "affilname": "Universit\u00e0 degli Studi di Milano",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030318",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Santander",
            "@id": "60020591",
            "affilname": "Hospital Universitario Marqu\u00e9s de Valdecilla",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020591",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "New York",
            "@id": "60007997",
            "affilname": "Weill Cornell Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007997",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Milan",
            "@id": "60006583",
            "affilname": "Fondazione IRCCS Istituto Nazionale dei Tumori, Milan",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006583",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Baltimore",
            "@id": "60005248",
            "affilname": "Johns Hopkins University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005248",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "Associazione italiana contro le leucemie-linfomi e mieloma Milano e Provincia ONLUS",
        "National Cancer Institute Cancer Center Support",
        "Research Institute of Marques de Valdecilla Wenceslao-Lopez-Albo",
        "National Institutes of Health",
        "American-Italian Cancer Foundation"
    ]
}